Tenet Healthcare Issues $2B 6.25% Senior Notes Due 2034

What Happened Tenet Healthcare Corporation announced on September 22, 2026 that it issued $2.0 billion aggregate principal amount of 6.250% senior notes due 2034 under a supplemental indenture to its existing indenture (the Forty-Third Supplemental Indenture). The company stated it intends to use the net proceeds, together with cash on hand, to redeem all $1.5 billion outstanding of its 5.125% senior secured first lien notes due November 2027 and to partially redeem $0.5 billion of its 6.125% senior notes due October 2028.

Key Details

• Issuance: $2.0 billion of 6.250% senior notes due 2034, issued September 22, 2026.
• Use of proceeds: Redeem $1.5 billion of 5.125% secured first‑lien notes due Nov 2027 and $0.5 billion of 6.125% notes due Oct 2028.
• Indenture terms: Notes issued under the company’s Base Indenture (dated Nov 6, 2001) as supplemented by the Forty‑Third Supplemental Indenture; trustee is The Bank of New York Mellon Trust Company, N.A.
• Covenants and features: Restrictions on liens, sale‑leasebacks and certain mergers, but with important exceptions; change‑of‑control redemption provisions; company may redeem notes (in whole or in part) with a make‑whole premium prior to Sept 15, 2029 and at specified percentages thereafter.

Why It Matters This transaction replaces near‑term debt with a longer‑dated unsecured obligation due 2034, moving $2.0 billion of nearer maturities out to 2034 and changing the company’s debt maturity profile. The indenture includes customary covenants and redemption features but preserves broad flexibility for Tenet and its subsidiaries to incur additional indebtedness, make restricted payments, and engage in other corporate actions. Investors should note the shift in maturity and the stated plan to use proceeds to retire the 2027 and 2028 notes, which affects the company’s upcoming refinancing needs and liability timeline.